Opportunities to improve immune-based prevention of HPV-associated cancers
Immunization of adolescent girls with VLP vaccines, made of L1 proteins from the most medically significant high risk HPV types, is a major strategy for prevention of cervical cancer plus other HPV-associated cancers. Maximal population impact, including through herd immunity, requires high vaccinat...
Main Authors: | Peter L. Stern, Richard BS. Roden |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852119300084 |
Similar Items
-
Immunizing against Anogenital Cancer: HPV Vaccines.
by: Cloe S Pogoda, et al.
Published: (2016-05-01) -
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
by: Archana Monie, et al.
Published: (2008-03-01) -
HPV AND CERVICAL CANCER PREVENTION
by: Marjetka Uršič-Vrščaj, et al.
Published: (2018-02-01) -
Photodynamic therapy in the prevention of HPV-associated cervical cancer recurrence
by: O I Trushina, et al.
Published: (2014-08-01) -
Cervical Cancer Prevention with HPV Vaccines
by: Chaivanee Kaosayapandhu
Published: (2017-04-01)